Home NDC 87706-866 ZAYNICH
Product NDC 87706-866
11-digit product format 877060866
Labeler code 87706
Product ID 87706-866_5381b2e7-e719-2af8-e063-6294a90a2732
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name zidebactam dihydrate and cefepime hydrochloride
Dosage form INJECTION, POWDER, FOR SOLUTION
Route INTRAVENOUS
Labeler Wockhardt Suisse USA LLC
Application NDA220787
Marketing category NDA
Marketing start 2026-05-29
Substance ZIDEBACTAM DIHYDRATE; CEFEPIME HYDROCHLORIDE
Active strength 1; 2 g/1; g/1
Pharmacologic classes Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N220787-001 ZAYNICH CEFEPIME HYDROCHLORIDE; ZIDEBACTAM EQ 2GM BASE/VIAL;1GM/VIAL POWDER / INTRAVENOUS RLD, RS 2026-05-29
Orange Book patents# Current patent rows page 1 of 1 · 7 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N220787-001 8822450 2032-08-24 Drug substance, Drug product 2026-06-15 N220787-001 8853197 2032-08-24 Drug substance 2026-06-15 N220787-001 9132133 2032-08-24 U-4558 2026-06-15 N220787-001 9381200 2032-08-24 Drug product 2026-06-15 N220787-001 9827235 2032-08-24 U-4558 Drug product 2026-06-15 N220787-001 9657021 2033-10-12 Drug substance 2026-06-15 N220787-001 9834557 2033-10-12 Drug substance 2026-06-15
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N220787-001 NCE 2031-05-29 N220787-001 GAIN 2036-05-29
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N220787-001 ZAYNICH EQ 2GM BASE/VIAL;1GM/VIAL POWDER / INTRAVENOUS RLD, RS 2026-05-29 84e616aacf4f…2026-08-18 06:07:40 2026-07 N220787-001 ZAYNICH EQ 2GM BASE/VIAL;1GM/VIAL POWDER / INTRAVENOUS RLD, RS 2026-05-29 caaa826d4ba7…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220787-001 ZAYNICH EQ 2GM BASE/VIAL;1GM/VIAL POWDER / INTRAVENOUS RLD, RS 2026-05-29 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N220787-001 8822450 2032-08-24 Drug substance, Drug product 2026-06-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 N220787-001 8853197 2032-08-24 Drug substance 2026-06-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 N220787-001 9132133 2032-08-24 U-4558 2026-06-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 N220787-001 9381200 2032-08-24 Drug product 2026-06-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 N220787-001 9827235 2032-08-24 U-4558 Drug product 2026-06-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 N220787-001 9657021 2033-10-12 Drug substance 2026-06-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 N220787-001 9834557 2033-10-12 Drug substance 2026-06-15 84e616aacf4f…2026-08-18 06:07:40 2026-07 N220787-001 8822450 2032-08-24 Drug substance, Drug product 2026-06-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N220787-001 8853197 2032-08-24 Drug substance 2026-06-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N220787-001 9132133 2032-08-24 U-4558 2026-06-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N220787-001 9381200 2032-08-24 Drug product 2026-06-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N220787-001 9827235 2032-08-24 U-4558 Drug product 2026-06-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N220787-001 9657021 2033-10-12 Drug substance 2026-06-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N220787-001 9834557 2033-10-12 Drug substance 2026-06-15 caaa826d4ba7…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220787-001 8822450 2032-08-24 Drug substance, Drug product 2026-06-15 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220787-001 8853197 2032-08-24 Drug substance 2026-06-15 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220787-001 9132133 2032-08-24 U-4558 2026-06-15 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220787-001 9381200 2032-08-24 Drug product 2026-06-15 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220787-001 9827235 2032-08-24 U-4558 Drug product 2026-06-15 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220787-001 9657021 2033-10-12 Drug substance 2026-06-15 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220787-001 9834557 2033-10-12 Drug substance 2026-06-15 a50c72e98297…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-09-14 22:38:34 2026-08 N220787-001 NCE 2031-05-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N220787-001 GAIN 2036-05-29 84e616aacf4f…2026-08-18 06:07:40 2026-07 N220787-001 NCE 2031-05-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N220787-001 GAIN 2036-05-29 caaa826d4ba7…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220787-001 NCE 2031-05-29 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220787-001 GAIN 2036-05-29 a50c72e98297…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base ZAYNICH
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ZIDEBACTAM DIHYDRATE 1 g/1 CEFEPIME HYDROCHLORIDE 2 g/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination TE54T8WC4T Internal UNII lookup I8X1O0607P Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2744819 Internal RxNorm lookup 2744824 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join ZAYNICH ZIDEBACTAM DIHYDRATE AND CEFEPIME HYDROCHLORIDE Wockhardt Suisse USA LLC c84e652e-5e76-4568-8812-bd5fa34803b6 2026-06-05 Warnings, Adverse reactions Exact identifier application applno (NDA): 220787 application number: NDA220787 ndc (product): 87706-866
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 87706-866-01 87706086601 1 VIAL, SINGLE-DOSE in 1 CARTON (87706-866-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (87706-866-00) 2026-05-29 No No Current